Nontuberculous pulmonary mycobacteriosis in Denmark: Incidence and prognostic factors

American Journal of Respiratory and Critical Care Medicine

Volumn 181, Issue 5, 2010, Pages 514-521

  Andréjak, Claire ^a,b   Thomsen, Vibeke Ø ^c   Johansen, Isik S ^c,d   Riis, Anders ^a   Benfield, Thomas L ^d   Duhaut, Pierre ^b   Sørensen, Henrik T ^a   Lescure, Francxois Xavier ^e   Thomsen, Reimar W ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b AMIENS UNIVERSITY HOSPITAL   (France)

^c STATENS SERUM INSTITUT   (Denmark)

^d HVIDOVRE HOSPITAL   (Denmark)

^e HÔPITAL TENON   (France)

Author keywords

Atypical mycobacteria; Epidemiological study; Incidence; Mortality

Indexed keywords

ADULT; AGED; ARTICLE; BACTERIAL COLONIZATION; BACTERIUM CULTURE; BACTERIUM DETECTION; COMORBIDITY; COMPARATIVE STUDY; DATA BASE; DEMOGRAPHY; DENMARK; FEMALE; GROUPS BY AGE; HUMAN; INCIDENCE; LUNG INFECTION; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; MYCOBACTERIOSIS; MYCOBACTERIUM GORDONAE; MYCOBACTERIUM INTRACELLULARE AVIUM; MYCOBACTERIUM MALMOENSE; MYCOBACTERIUM XENOPEI; NONTUBERCULOUS PULMONARY MYCOBACTERIOSIS; PRIORITY JOURNAL; PROGNOSIS; SEX DIFFERENCE;

ADOLESCENT; ADULT; AGE FACTORS; CARDIOVASCULAR DISEASES; DENMARK; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; MYCOBACTERIA, ATYPICAL; MYCOBACTERIUM INFECTIONS, ATYPICAL; PROGNOSIS; SEX FACTORS; SURVIVAL ANALYSIS; TUBERCULOSIS, PULMONARY; YOUNG ADULT;

EID: 77649148255     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/rccm.200905-0778OC     Document Type: Article

References (30)

1. Griffith DE, Aksamit T, Brown-Eliott BA, Catanzaro A, Daley C, Gordin F, Holland SM, Horsburgh R, Huitt G, Iademarco MF, et al. An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med 2007;175:367-416.
2. Dailloux M, Abalain ML, Laurain C, Lebrun L, Loos-Ayav C, Lozniewski A, Maugein J. French Mycobacteria Study Group. Respiratory infections associated with nontuberculous mycobacteria in non-HIV patients. Eur Respir J 2006;28:1211-1215.
3. O'Brien R, Geiter LJ, Snider DE. The epidemiology of nontuberculous mycobacterial diseases in the United States. Results from a national survey. Am Rev Respir Dis 1987;135:1007-1014.
4. Marras TK, Daley CL. Epidemiology of human pulmonary infection with nontuberculous mycobacteria. Clin Chest Med 2002;53:553-567.
5. Falkinham JO. Epidemiology of infection by nontuberculous mycobacteria. Clin Microbiol Rev 1996;9:177-215.
6. British Thoracic Society. Management of opportunist mycobacterial infections: Joint Tuberculosis Committee guidelines 1999. Thorax 2000;55:210-218.
7. Yates MD, Pozniak A, Uttley AHC, Clarke R, Grange JM. Isolation of environmental mycobacteria from clinical specimens in South East England: 1973-1993. Int J Tuberc Lung Dis 1997;1:75-80.
8. Andréjak C, Lescure FX, Douadi Y, Laurans G, Smail A, Duhaut P, Jounieaux V, Schmit JL. Non-tuberculous mycobacteria pulmonary infection: management and follow-up of 31 infected patients. J Infect 2007;55:34-40.
9. Marras TK, Chedore P, Ying AM, Jamieson F. Isolation prevalence of pulmonary nontuberculous mycobacteria in Ontario, 1997-2003. Thorax 2007;62:661-666.
10. Cox JN, Brenner ER, Bryan CS. Changing pattern of mycobacterial disease at a teaching community hospital. Infect Control Hosp Epidemiol 1994;15:513-515.
11. Martin-Casabona N, Bahrmand AR, Bennedsen J, Østergaard Thomsen V, Curcio M, Fauville-Dufaux M, Feldman K, Havelkova M, Katila ML, Köksalan K, et al. Spanish Group for Non-tuberculosis Mycobacteria. Non-tuberculous mycobacteria: patterns of isolation. A multi-country retrospective survey. Int J Tuberc Lung Dis 2004;8: 1186-1193.
12. Andréjak C, Lescure FX, Pukenyte E, Douadi Y, Yazdanpanah Y, Laurans G, Schmit JL, Jounieaux V, and the Xenopi group. Mycobacterium xenopi pulmonary infections: a multicentric retrospective study of 136 cases in North East France. Clinical and radiological features, treatment and outcome. Thorax 2009;64:291-296.
13. Research Committee of the British Thoracic Society. First randomized trial of treatment for pulmonary disease caused by M. avium intracellulare, M. malmoense and M. xenopi in HIV negative patients: rifampicin, ethambutol and isoniazid versus rifampicin and ethambutol. Thorax 2001;56:167-172.
14. Al Jarad N, Demertzis P, Jones DJ, Barnes NC, Rudd RM, Gaya H, Wedzicha JA, Hughes DT, Empey DW. Comparison of characteristics of patients and treatment outcome for pulmonary non-tuberculous mycobacterial infection and pulmonary tuberculosis. Thorax 1996;51:137-139.
15. Andréjak C, Thomsen VØ, Johansen IS, Riis A, Benfield T, Duhaut P, Sørensen HT, Lescure FX, Thomsen RW. Incidence of infection and colonization with nontuberculous mycobacteria in Denmark, 1997-2008: a nationwide population-based study. European Respiratory Society Congress. September 12-16, 2009, Vienna, Austria.
16. Andréjak C, Thomsen VØ, Johansen IS, Riis A, Benfield T, Duhaut P, Sørensen HT, Lescure FX, Thomsen RW. The prognosis of patients colonized and infected with pulmonary nontuberculous mycobacteria in Denmark, 1997-2007: a nationwide population-based study. European Respiratory Society Congress. September 12-16, 2009, Vienna, Austria.
17. Pedersen CB, Gøtzche H, Møller JO, Mortensen PB. The Danish Civil registration system. A cohort of eight million persons. Dan Med Bull 2006;53:441-449.
18. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987;40:373-383.
19. De Groot V, Beckerman H, Lankhorst GJ, Bouter LM. How to measure comorbidity. A critical review of available methods. J Clin Epidemiol 2003;56:221-229.
20. Thomsen RW, Riis A, Nørgaard M, Jacobsen J, Christensen S, McDonald CJ, Sørensen HT. Rising incidence and persistently high mortality of hospitalized pneumonia: a 10-year population-based study in Denmark. J Intern Med 2006;259:410-417.
21. Kornum JB, Thomsen RW, Riis A, Lervang HH, Schønheyder HC, Sørensen HT. Type 2 diabetes and pneumonia outcomes. A population-based cohort study. Diabetes Care 2007;30:2251-2257.
22. Koh WJ, Kwon OJ, Jeon K, Kim TS, Lee KS, Park YK, Bai GH. Clinical significance of nontuberculous mycobacterial isolated from respiratory specimens in Korea. Chest 2006;129:341-348.
23. Thomsen VØ, Andersen ÅB, Miörner H. Incidence and clinical significance of nontuberculous Mycobacteria isolated from clinical specimens during a 2-y nationwide survey. Scand J Infect Dis 2002;34:648-653.
24. Freeman J, Morris A, Blackmore T, Hammer D, Munroe S, McKnight L. Incidence of nontuberculous mycobacterial disease in New Zealand. N Z Med J 2007;120:U2580.
25. Van Ingen J, Bendien SA, de Lange WCM, Hoefsloot W, Dekhuijzen PNR, Boeree MJ, van Soolingen D. Clinical relevance of nontuberculous mycobacteria isolated in the Nijmegen-Arnhem region, The Netherlands. Thorax 2009;64:502-506.
26. Donnabella V, Salazar-Schicchi J, Bonk S, Hanna B, Rom WN. Increasing incidence of Mycobacterium xenopi at Bellevue Hospital: An emerging pathogen or a product of improved laboratory methods? Chest 2000;118:1365-1370.
27. Billinger ME, Olivier KN, Viboud C, Montes de Oca R, Steiner C, Holland SM, Prevots DR. Nontuberculous mycobacteria associated lung disease in hospitalized persons, United States, 1998-2005. Emerg Infect Dis 2009;15:1562-1569.
28. Sexton P, Harrison AC. Susceptibility to nontuberculous mycobacterial lung disease. Eur Respir J 2008;31:1322-1333.
29. Jenkins PA, Campbell IA, Banks J, Gelder CM, Prescott RJ, Smith AP. Clarithromycin versus ciprofloxacin as adjuncts to rifampicin and ethambutol in treating opportunist mycobacterial lung diseases and an assessment of Mycobacterium vaccae immunotherapy. Thorax 2008;63:627-634.
30. Prince DS, Peterson DD, Steiner RM, Gottlieb JE, Scott R, Israel HL, Figueroa WG, Fish JE. Infection with Mycobacterium avium complex in patients without predisposing conditions. N Engl J Med 1989;321: 863-868.